Andrew Zappia, a partner in Troutman Pepper Locke's Insurance + Intellectual Property practice group.

24 November 2025FeaturesAmericasAndrew Zappia

Still Unsettling: The uncertain landscape for discretionary denial

The USPTO’s ‘settled expectations’ rule is anything but settled, argues Andrew Zappia of Troutman Pepper Locke.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

A second bite at the cherry: Adjudicating redesigns after an ITC exclusion order

23 October 2025 Parties impacted by exclusion orders need to carefully weigh their options for seeking clarity or rulings on redesigns, explain Daniel Muino and Charles Provine from Morrison Foerster.

Americas

How impactful is the new USPTO director’s S101 decision?

2 October 2025 As John Squires makes the bold move to allow patentability of an AI-related invention in Ex parte Desjardins, experts broadly welcome the decision—but encourage some caution, finds Sarah Speight.

Americas

A step too far? Why Stewart’s approach is dividing opinion

24 June 2025 Coke Morgan Stewart has issued a raft of decisions under new guidance intended to improve the US patent appeals board process. But it’s a divisive issue, finds Sarah Speight.

More features

Ex-Teva counsel and FDA regulatory specialist returns to private practice

Use of genAI to draft patents ‘a big concern’: CIPA’s AI chair

MSD wins full sweep in world’s best-selling drug clash

INTA votes in new 2026 president at Florida leadership meeting

Sandoz wins Fed Circ reversal of $39m hair loss patent verdict

Perkins Coie and Ashurst to merge into $2.7bn revenue firm

Sanofi unit defends booster vaccine trademark in Europe

Pillsbury bags first-chair litigator and inventor with ‘business acumen’

Still Unsettling: The uncertain landscape for discretionary denial

More on this story

Editor's picks

Editor's picks

More features